JOHANNE PIERRE: Open Payments
NPI 1568022895 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,680 in 28 payments from 12 companies in 2025. Trend: 2023 $2,650 · 2024 $2,157 · 2025 $2,680
Food & beverage: $1,376Consulting: $1,155Education: $149
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 2 | $1,087 |
| Incyte Corporation | 7 | $460 |
| PFIZER INC. | 2 | $294 |
| ADC THERAPEUTICS AMERICA, INC. | 7 | $269 |
| Teleflex LLC | 1 | $154 |
| BeOne Medicines USA, Inc. | 1 | $129 |
| Janssen Biotech, Inc. | 3 | $125 |
| SOBI, INC | 1 | $35 |
| Lilly USA, LLC | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
Products named: EPKINLY, MONJUVI, ZYNLONTA, ELREXFIO, ARROW, BRUKINSA, ADCETRIS, DARZALEX.
Industry payments across TX — which companies pay providers there.
